866-997-4948(US-Canada Toll Free)

Miraculins Inc. (MOM) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Oct 2012

Category :

Competitive Analysis

No. of Pages : 37 Pages


Miraculins Inc (Miraculins) is a pharmaceuticals company, based in Canada. The company develops and commercializes diagnostic tests for Unmet Clinical Needs. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and therapeutic products. Miraculins products include PREVU Skin Cholesterol Test and PSP94 Immunoassay for Urine Specimens. Miraculins also provides research and development services. The companys testing services utilizes PSP94 RUO kit. It utilizes the B.E.S.T Platform technology for screening and identification of target proteins and peptides related to diseases. Miraculins entered into an agreement with Inverness Medical Innovations, Inc., a developer of consumer medical diagnostic products, for the development and commercialization of Miraculins preeclampsia technology. Miraculins is headquartered in Manitoba, Canada.

This report is a source for data, analysis and actionable intelligence on the Miraculins Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Content
List of Tables
List of Figures

Key Facts
Miraculins Inc. - Major Products and Services
Miraculins Inc. Pipeline Products by Equipment Type
Miraculins Inc. Pipeline Products by Development Stage
Miraculins Inc. Pipeline Products by Therapy Area
Miraculins Inc. Pipeline Products by Trial Phase
Miraculins Inc. Pipeline Products by Milestone Summary
Diagnostic Test - Colorectal Cancer
Diagnostic Test - Colorectal Cancer Product Status
Diagnostic Test - Colorectal Cancer Product Description
Diagnostic Test - Gastric Cancer
Diagnostic Test - Gastric Cancer Product Status
Diagnostic Test - Gastric Cancer Product Description
Diagnostic Test - Gastric Cancer Product Milestone
Diagnostic Test - Gastric Cancer Clinical Trial
Diagnostic Test - Pancreatic Cancer
Diagnostic Test - Pancreatic Cancer Product Status
Diagnostic Test - Pancreatic Cancer Product Description
Diagnostic Test - Preeclampsia
Diagnostic Test - Preeclampsia Product Status
Diagnostic Test - Preeclampsia Product Description
Diagnostic Test - Prostate Cancer
Diagnostic Test - Prostate Cancer Product Status
Diagnostic Test - Prostate Cancer Product Description
Diagnostic Test - Prostate Cancer Product Milestone
Diagnostic Test - Prostate Cancer Clinical Trial
PREVU Skin Cholesterol Test
PREVU Skin Cholesterol Test Product Status
PREVU Skin Cholesterol Test Product Description
PREVU Skin Cholesterol Test Product Milestone
PREVU Skin Cholesterol Test Clinical Trial
Miraculins Inc. - Key Competitors
Miraculins Inc. - Key Employees
Miraculins Inc. - Locations And Subsidiaries
Head Office
Recent Developments
Miraculins Inc., Recent Developments
Jan 12, 2012: Alere Maintains Exclusive Option To License Miraculins
Dec 23, 2011: Miraculins Appoints Dr Milan Gupta To PreVu Medical Advisory Board
Dec 23, 2011: Miraculins Names James Kinley As CFO
Dec 21, 2011: Miraculins Successfully Passes Critical ISO 13485 Certification Audit
Dec 08, 2011: Miraculins Appoints William Roberts To Board
Nov 01, 2011: Miraculins Announces Board Changes
Jul 15, 2011: Miraculins Appoints April Manness As New Interim CFO
Jun 13, 2011: Alere Maintains Exclusive Option On Miraculins’ Preeclampsia Technology
May 31, 2011: Miraculins Announces New Board Members
Mar 30, 2011: Miraculins Appoints David Howard To Board Of Directors

Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Table


Miraculins Inc., Key Facts
Miraculins Inc. Key Pipeline Products by Equipment Type
Miraculins Inc. Key Pipeline Products by Therapy Area
Miraculins Inc. Key Pipeline Products by Development Stage
Miraculins Inc. Key Pipeline Products by Trial Phase
Miraculins Inc., Key Facts
Miraculins Inc., Major Products and Services
Miraculins Inc. Number of Pipeline Products by Equipment Type
Miraculins Inc. Pipeline Products by Equipment Type
Miraculins Inc. Number of Pipeline Products by Development Stage
Miraculins Inc. Pipeline Products by Development Stage
Miraculins Inc. Number of Pipeline Products by Therapy Area
Miraculins Inc. Pipeline Products by Therapy Area
Miraculins Inc. Number of Pipeline Products by Trial Phase
Miraculins Inc. Pipeline Products by Trial Phase
Miraculins Inc. Number of Pipeline Products By Milestone Summary
Miraculins Inc. Pipeline Products by Milestone Summary
Diagnostic Test - Colorectal Cancer - Product Status
Diagnostic Test - Colorectal Cancer - Product Description
Diagnostic Test - Gastric Cancer - Product Status
Diagnostic Test - Gastric Cancer - Product Description
Diagnostic Test - Gastric Cancer - Product Milestone
Diagnostic Test - Gastric Cancer - Internal Review Confirms Set of Compelling Markers in Gastric cancer diagnostic test
Diagnostic Test - Pancreatic Cancer - Product Status
Diagnostic Test - Pancreatic Cancer - Product Description
Diagnostic Test - Preeclampsia - Product Status
Diagnostic Test - Preeclampsia - Product Description
Diagnostic Test - Prostate Cancer - Product Status
Diagnostic Test - Prostate Cancer - Product Description
Diagnostic Test - Prostate Cancer - Product Milestone
Diagnostic Test - Prostate Cancer - 2nd Pivotal Study for P2V Prostate Cancer Test
Diagnostic Test - Prostate Cancer - First Pivotal Study For Prostate Cancer Diagnostic Test
PREVU Skin Cholesterol Test - Product Status
PREVU Skin Cholesterol Test - Product Description
PREVU Skin Cholesterol Test - Product Milestone
PREVU Skin Cholesterol Test - Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Miraculins Inc., Key Employees

List of Chart


Miraculins Inc. Key Pipeline Products by Equipment Type
Miraculins Inc. Pipeline Products by Equipment Type
Miraculins Inc. Pipeline Products by Development Stage
Miraculins Inc. Pipeline Products by Therapy Area
Miraculins Inc. Pipeline Products by Trial Phase
Miraculins Inc. Pipeline Products by Milestone Summary

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *